Global Drug of Abuse Testing Market to amass $ 4.8 Bn by 2025

December 17, 2019


According to the new research report available at MarketStudyReport.com under the title ‘Drug of Abuse Testing Market Size By Product (Analyzers {Breath Analyzers Immunoassay Analyzers, Chromatographic Analyzers}), Rapid Testing Devices, Consumables), By Sample (Urine, Saliva, Hair), By End-use (Hospitals, Forensic Laboratories, Diagnostic Laboratories, Law Enforcement Agencies), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, Japan, China, India, Australia, Brazil, Mexico, South Africa, GCC Countries), Application Potential, Competitive Market Share & Forecast, 2019 – 2025’, the global drug of abuse testing market is projected to cross USD 4.8 billion by the year 2025.
 

Growing occurrences of drug abuse incidents across the globe is a major factor driving the drug of abuse (DOA) testing market. Favorable federal reforms regarding applications of drug abuse testing system is also aiding in the market expansion. Rising number of clinical laboratories in emerging nations that effectively measures health of the patient is augmenting the demand for drug of abuse testing devices across the globe. Furthermore, rising adoption rates of drug of abuse testing systems in law enforcement department in tandem with technological advancement in drug abuse treatment is contributing towards the growth of the market.
 

In terms of product type, rapid testing devices market was worth USD 1 billion in 2018 and is expected to grow substantially during the estimated timeframe. Rapid testing systems not only provide accurate results but also reduce the time taken for on-site screening procedures. Thus, increasing adoption of rapid testing devices instead of traditional devices is accelerating the segmental growth.
 

As per sample type, DOB testing market from saliva segment is expected to grow with a CAGR of 6% during the period of 2019-2025, owing to extensive use of these devices in addiction treatment settings. Drugs appear in oral fluids from bloodstream to salivary glands through passive diffusion. Saliva as sample enable presumptive detection of drugs such as cocaine, amphetamines, opiates, heroine, and methamphetamine.
 

Speaking of end-use spectrum, DOB testing market from law enforcement agencies segment was worth USD 700 million in 2018 and is expected to grow significantly during the forecast period. Growing demand for rapid testing devices and analyzers for routinized testing is fueling the drug of abuse testing market growth.
 

Request sample copy of this Report@ https://www.marketstudyreport.com/request-a-sample/2337489/
 

Considering the geographical landscape, UK drug of abuse testing industry grew with a CAGR of 4.5% over the past years, owing to the availability of advanced devices across the country. Strict government regulations, in tandem with high workplace drug testing standards are also contributing towards the regional market growth.
 

The prominent companies operating in the drug of abuse testing market are Lab Corps of America Holdings, F. Hoffmann-La Roche, Drägerwerk AG, Abbott Laboratories, Siemens, Thermo Fisher Scientific, Randox Testing Services, Beckman Coulter, Quest Diagnostics, and United States Drug Testing Laboratories.


Frequently Asked Questions (FAQ) :

Growing occurrences of drug abuse incidents across the globe is a major factor driving the drug of abuse testing market. Favorable federal reforms regarding applications of drug abuse testing system is also aiding in the market expansion. Rising number of clinical laboratories in emerging nations that effectively measures health of the patient is augmenting the demand for drug of abuse testing devices across the globe. Furthermore, rising adoption rates of drug of abuse testing systems in law enforcement department in tandem with technological advancement in drug abuse treatment is contributing towards the growth of the market.
Drug of abuse testing market from rapid testing devices segment was worth USD 1 billion in 2018 and is expected to grow substantially during the estimated timeframe. Rapid testing systems not only provide accurate results but also reduce the time taken for on-site screening procedures. Thus, increasing adoption of rapid testing devices instead of traditional devices is accelerating the segmental growth.
The UK drug of abuse testing industry grew with a CAGR of 4.5% over the past years, owing to the availability of advanced devices across the country. Strict government regulations in tandem with high workplace drug testing standards are also contributing towards the regional market growth.
The prominent companies operating in the drug of abuse testing market are Drägerwerk AG, Lab Corps of America Holdings, F. Hoffmann-La Roche, Abbott Laboratories (Alere), Thermo Fisher Scientific) Randox Testing Services, Beckman Coulter (Danaher), Siemens, Quest Diagnostics, and United States Drug Testing Laboratories.